ビス(2,4-ペンタンジオナト)パラジウム(II)

Palladium acetylacetonate

HCID 5486778

基本情報

CAS
14024-61-4
標準SMILES
CC(=O)/C=C(/C)[O-].CC(=O)/C=C(/C)[O-].[Pd+2]
InChIKey
JKDRQYIYVJVOPF-FDGPNNRMSA-L
分子式
C10H14O4Pd
平均分子量
304.64 g/mol
単同位体質量
303.99269

名称と識別子

優先名称
Palladium acetylacetonate
IUPAC
bis((Z)-4-oxopent-2-en-2-olate);palladium(2+)
現地名
ビス(2,4-ペンタンジオナト)パラジウム(II)
英語名
Bis(2,4-pentanedionato-O,O')palladium(II)
分子式
C10H14O4Pd
分子量
304.64

名称と別名

14024-61-4RefChem:858315PALLADIUM(2+) ION BIS(4-OXOPENT-2-EN-2-OLATE)Palladium acetylacetonatePalladium(II) acetylacetonatePalladium bis(acetoacetonate)Pd(acac)2Bis(acetylacetonato)palladium(Z)-4-oxopent-2-en-2-olate;palladium(2+)Palladium-2,4-pentanedionatePalladium, bis(2,4-pentanedionato-kappaO2,kappaO4)-, (SP-4-1)-palladium (II) acetylacetonate
名称をさらに表示
ビス(2,4-ペンタンジオナト)パラジウム(II)パラジウム(II)アセチルアセトネートパラジウム(II)アセチルアセトナートアセチルアセトンパラジウム(Ⅱ)アセチルアセトンパラジウム(II)ビスアセチルアセトナートパラジウム(II)ビス(アセチルアセトナト)パラジウム(II)パラジウム(II)アセチルアセトンビス(アセチルアセトナト)パラジウム(Ⅱ)2,4-ペンタンジオン酸パラジウム(II), Pd 34.7%BIS(ACETYLACETONATO)PALLADIUM(II)ACETYLACETONE PALLADIUM(II) SALTBIS(2,4-PENTANEDIONATO)PALLADIUM(II)ACETYLACETONE, PALLADIUM(II) DERIVATIVE34.7%PdUmicore, 99%Palladium acet
EINECS 237-859-8Palladium, bis(2,4-pentanedionato)-NSC 187660Palladium (II) di(4-oxopent-2-en-2-oate)palladium(II)acetylacetonate6G7QUC3M5JSCHEMBL144097Palladium, bis(2,4-pentanedionato-O,O')-, (SP-4-1)-

データベース識別子

CAS
14024-61-4
PubChem CID
5486778
UNII
6G7QUC3M5J
EC Number
237-859-8

物性

構造計算による物性

極性表面積
80.3 Ų
水素結合供与体数
0
水素結合受容体数
4
回転可能結合数
2
重原子数
15

物理化学的性質

融点
190 °C · 190 °C
沸点
300 °/0.1mm · 300°/0.1mm
蒸気圧
0 Pa · 0Pa at 25℃
貯蔵温度
30 °C · Store below +30°C.
溶解性
ベンゼン、クロロホルムに可溶。
外見
解決

化学的性質

化学的特性yellow orange needles

安全と法規制

GHS分類

GHS Classification · 5 件

Danger

H228 (61.5%): Flammable solid [Danger Flammable solids];H251 (26.6%): Self-heating; may catch fire [Danger Self-heating substances and mixtures];H302 (25.7%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (36.7%): Causes skin irritation [Warning Skin corrosion/irritation];H317 (24.8%): May cause an allergic skin reaction [Warning Sensitization, Skin];H318 (24.8%): Causes serious eye damage [Danger Serious eye damage/eye irritation];H319 (73.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (34.9%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation];H400 (24.8%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard];H410 (24.8%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard]

P210, P235, P240, P241, P261, P264, P264+P265, P270, P271, P272, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P370+P378, P391, P403+P233, P405, P407, P410, P413, P420, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 109 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

危険有害性情報

Regulatory Information · 3 件

Chemical: Palladium, bis(2,4-pentanedionato-O,O')-, (SP-4-1)-

Status: Active Update: 25-11-2020 https://echa.europa.eu/registration-dossier/-/registered-dossier/18885

Palladium, bis(2,4-pentanedionato-.kappa.O,.kappa.O')-, (SP-4-1)-: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Palladium, bis(2,4-pentanedionato-O,O')-, (SP-4-1)-: Human health tier I assessment;IMAP assessments - Palladium, bis(2,4-pentanedionato-O,O')-, (SP-4-1)-: Environment tier I assessment
Hazard Classes and CategoriesFlam. Sol. 1 (61.5%);Self-heat. 1 (26.6%);Acute Tox. 4 (25.7%);Skin Irrit. 2 (36.7%);Skin Sens. 1 (24.8%);Eye Dam. 1 (24.8%);Eye Irrit. 2 (73.4%);STOT SE 3 (34.9%);Aquatic Acute 1 (24.8%);Aquatic Chronic 1 (24.8%)

毒性情報

Health Effects · 2 件

Contact with palladium may cause palladium sensitivity and allergy. Animal studies have shown that palladium may damage the liver and kidney. (L798)

Contact with palladium may cause palladium sensitivity and allergy. Animal studies have shown that palladium may damage the liver and kidney. (L798)

Toxicity Summary · 2 件

Due to their ability to form strong complexes with both inorganic and organic ligands, palladium ions can disturb cellular equilibria, replace other essential ions, and interact with functional groups of macromolecules, such as proteins or DNA. Palladium complexes binding to DNA and RNA leads to strand breakage. Palladium ions are able to inhibit most major cellular functions, including DNA and RNA synthesis. Palladium compounds have been shown to bind to and inhibit various enzymes, including creatine kinase and prolyl hydroxylase. (L798)

Due to their ability to form strong complexes with both inorganic and organic ligands, palladium ions can disturb cellular equilibria, replace other essential ions, and interact with functional groups of macromolecules, such as proteins or DNA. Palladium complexes binding to DNA and RNA leads to strand breakage. Palladium ions are able to inhibit most major cellular functions, including DNA and RNA synthesis. Palladium compounds have been shown to bind to and inhibit various enzymes, including creatine kinase and prolyl hydroxylase. (L798)

Signs and Symptoms · 2 件

Skin contact with palladium may cause contact dermatitis, erythema, and oedema. (L798)

Skin contact with palladium may cause contact dermatitis, erythema, and oedema. (L798)

Carcinogen Classification · 2 件

No indication of carcinogenicity to humans (not listed by IARC).

No indication of carcinogenicity to humans (not listed by IARC).

法規制情報

Regulatory Information · 3 件

Chemical: Palladium, bis(2,4-pentanedionato-O,O')-, (SP-4-1)-

Status: Active Update: 25-11-2020 https://echa.europa.eu/registration-dossier/-/registered-dossier/18885

Palladium, bis(2,4-pentanedionato-.kappa.O,.kappa.O')-, (SP-4-1)-: Does not have an individual approval but may be used under an appropriate group standard

安全データ

wgk
2
tsca
TSCA listed
ridadr
3181
hs_code
28439090
risk_code
36-36/37/38-22
化審法
(2)-2181

化学と産業

薬理情報

Metabolism/Metabolites · 2 件

Palladium may be absorbed through oral, dermal, and inhalation exposure. Once in the body it distributes to the kidney, liver, spleen, lymph nodes, adrenal gland, lung and bone. Palladium's ability to form complexes allows it the bind to amino acids, proteins, DNA, and other macromolecules. Palladium and its metabolites are excreted in the urine and faeces. (A21)

Palladium may be absorbed through oral, dermal, and inhalation exposure. Once in the body it distributes to the kidney, liver, spleen, lymph nodes, adrenal gland, lung and bone. Palladium's ability to form complexes allows it the bind to amino acids, proteins, DNA, and other macromolecules. Palladium and its metabolites are excreted in the urine and faeces. (A21)

用途と製造

General Manufacturing InformationPalladium, bis(2,4-pentanedionato-.kappa.O2,.kappa.O4)-, (SP-4-1)-: ACTIVE
応用分野 · 3 件

用途有機合成用均質触媒。

使用Palladium(II) Acetylacetonate is an active anticancer agent. Exhibits growth inhibitory effect more than cisplatin in several cancer cells and treatment with Palladium(II) Acetylacetonate inhibits H460 cells. Palladium(II) Acetylacetonate is a catalyst for various organic transformations.

一般的な説明Palladium(II) acetylacetonate (Pd(acac)2) is a metal-organic complex. Sublimation of Pd(acac)2 has been investigated by thermogravimetry and XRD. The temperature range for the sublimation of Pd(acac)2, without undergoing thermal decomposition, was determined to be 100-160°C in the presence of inert gas helium.

調製方法 · 1 件

純化方法It can be recrystallised from *C6H6/pet ether and sublimes in vacuo. It is soluble in heptane, *C6H6 (1.2% at 20o, 2.2 at 40o), toluene (0.56% at 20o, 1.4% at 40o) and acetylacetone (1.2% at 20o, 0.05% at 40o). [West & Riley J Inorg Nucl Chem 5 295 1957/8, Fernelius & Bryant Inorg Synth V 105 1957, Beilstein 1 IV 3676.]

サプライヤー103 社

国药集团化学试剂有限公司86-21-63210123 · [email protected]
北京华美互利生物化工010-56205725 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
VladaChem GmbH+49-7246-3082843 +86-18411632868 · [email protected]
T&W GROUP021-61551611 13296011611 · [email protected]

関連反応

25 件

化合物ノート

読み込み中…